Published in Pol Tyg Lek on December 14, 1987
Rho is a negative regulator of human monocyte spreading. J Immunol (1996) 1.27
Metabolism and mutagenic activity of benzo[k]fluoranthene and 3-, 8- and 9-fluorobenzo[k]fluoranthene. Carcinogenesis (1988) 0.78
[Disorders in carbohydrate metabolism in the acute period of myocardial infarction. I. Evaluation of insulin-like activity of serum and cellular uptake of glucose]. Pol Arch Med Wewn (1969) 0.78
Adrenergic responses to sustained handgrip in patients with juvenile-onset-type diabetes mellitus. Clin Sci Mol Med (1975) 0.77
The effect of different dietary levels of vitamin E and selenium on antioxidant status and immunological markers in serum of laying hens. Pol J Vet Sci (2013) 0.77
[Predicting the development of diabetes mellitus type 1]. Pol Tyg Lek (1992) 0.75
[Study of medicine based on the conceptual structure of science-- using the example of diabetology]. Pol Tyg Lek (1984) 0.75
[Medical philosophy: humanities in medicine]. Pol Tyg Lek (1985) 0.75
[Intensification of conventional insulin therapy of diabetes mellitus]. Pol Tyg Lek (1982) 0.75
Modification of gas-chromatographic method for blood chlorpropamide determination and evaluation of its use for clinical and pharmacological purposes. Pol J Pharmacol Pharm (1984) 0.75
[Determining the effect of a pectin-enriched standard diabetic diet on diurnal blood glucose profiles and serum insulin (IRI) levels in diabetes mellitus type 2]. Pol Tyg Lek (1984) 0.75
[Relative effectiveness of tolbutamide, chlorpropamide and gliclazide]. Pol Tyg Lek (1992) 0.75
[Influence of pre-conception pregnancy planning in women with diabetes mellitus I on the number of spontaneous abortions and major congenital malformations in their children]. Ginekol Pol (1999) 0.75
[Role of metabolism regulation disorders in fatty tissue cells in the pathogenesis of diabetogenic effect of obesity in humans]. Pol Arch Med Wewn (1975) 0.75
[Methods of evaluating the effectiveness of conventional treatment of diabetes mellitus]. Pol Tyg Lek (1982) 0.75
[Management of moderately severe diabetic ketoacidosis and diabetic coma]. Pol Tyg Lek (1981) 0.75
[From the area of medical philosophy: biological and cultural mechanisms in the development of man and his health]. Pol Tyg Lek (1985) 0.75
[Patient education in the treatment of diabetes mellitus]. Pol Tyg Lek (1984) 0.75
[Evaluation of intestinal absorption by xylose test in diabetic enteropathy]. Pol Arch Med Wewn (1971) 0.75
[Interdisciplinary aspects of the treatment of hypertension]. Przegl Lek (1989) 0.75
[Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)]. Przegl Lek (1979) 0.75
[Clinical-statistical analysis of 382 episodes of ketoacidosis and keto acidotic coma in patients with diabetes mellitus (author's transl)]. Przegl Lek (1979) 0.75
[Diurnal rhythm of prolactin secretion in patients with type I diabetes mellitus]. Pol Tyg Lek (1982) 0.75
[The self-education aspects of a physician's activity]. Pol Tyg Lek (1983) 0.75
[Pathogenesis and various clinical problems of cardiomyopathy in diabetes mellitus]. Pol Tyg Lek (1985) 0.75
[Pathophysiologic basis of arterial hypertension in diabetic patients]. Pol Tyg Lek (1993) 0.75
[Hypotheses with regard to the etiology of arteriosclerosis: contradictions and similarities]. Pol Tyg Lek (1982) 0.75
[Profile of the main risk factors of arteriosclerosis in patients with diabetes mellitus]. Pol Tyg Lek (1992) 0.75
[Molecular basis of insulin action on cells (author's transl)]. Przegl Lek (1979) 0.75
[Prolactin secretion in patients with diabetes mellitus - TRH or bromocriptine function tests]. Endokrynol Pol (1982) 0.75
[Senile anemias]. Pol Tyg Lek (1975) 0.75
[Method of indirect evaluation of the pharmacodynamic properties of new insulin preparations]. Pol Tyg Lek (1985) 0.75
[5 principles of rational management of diabetes in pregnancy]. Pol Tyg Lek (1982) 0.75
[DNA restriction fragment length polymorphism (RFLP) of insulin and apolipoprotein A-I (apo A-I) genes in patients with diabetes mellitus coexistent with polyendocrinopathy]. Pol Tyg Lek (1987) 0.75
[Comparison of the effectiveness of conventional and intensive insulin therapy in the treatment of diabetes mellitus type 1 in pregnant women or those planning pregnancy]. Pol Tyg Lek (1987) 0.75
[Autoimmune connections between diabetes and Addison-Biermeier disease]. Pol Tyg Lek (1973) 0.75
[On the subject of medical philosophy: what is medicine today?]. Pol Tyg Lek (1985) 0.75
[Molecular pathology of insulin-dependent diabetes mellitus (type I)]. Pol Tyg Lek (1990) 0.75
[Algorithm for the differential diagnosis of hyperlipidemia]. Pol Tyg Lek (1985) 0.75
[How to teach medicine, how to educate a physician?]. Pol Tyg Lek (1983) 0.75
[Pathophysiological principles of dose selecting and pharmacodynamic properties of insulin preparations for treatment of diabetes]. Pol Tyg Lek (1971) 0.75
[Advances in the treatment of ketoacidotic coma in patients with diabetes mellitus-analysis of clinical experience (author's transl)]. Przegl Lek (1979) 0.75
[Views with regard to the production and use of sweetening agent substitutes in the diet of patients with diabetes mellitus]. Pol Tyg Lek (1988) 0.75
Disturbances in cabohydrate metabolism at the acute stage of myocardial infarction. Pol Med J (1970) 0.75
[Treatment of hypertension in patients with diabetes mellitus]. Pol Tyg Lek (1984) 0.75
[Futuristic remarks on the development of the medical education system]. Pol Tyg Lek (1983) 0.75
[Pathophysiologic basis for obesity in diabetes type II]. Pol Tyg Lek (1995) 0.75
[Microcirculatory evaluation of the early diabetic foot syndrome using laser doppler]. Pol Merkur Lekarski (1997) 0.75
[Effect of pectins on glucose tolerance and insulinemia (IRI) in patients with diabetes mellitus type 2 associated with obesity]. Pol Tyg Lek (1984) 0.75
[Clinical aspects of lactic acid acidosis in the light of own observations (author's transl)]. Przegl Lek (1979) 0.75
Computation of the number of diabetics, as well as of diabetic genotypes and of the frequency of diabetic alleles in the Polish population above 14 years of age. Pol Med J (1971) 0.75
[Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives]. Pol Tyg Lek (1985) 0.75
[Prospective studies of diabetic retinopathy in a cohort of patients with type II diabetes mellitus]. Pol Merkur Lekarski (1997) 0.75
[Efficacy and tolerance of axetil cefuroxime for treatment of chronic urinary tract infection relapse in patients with diabetes mellitus]. Pol Tyg Lek (1996) 0.75
[Permissible physical effort criteria in juvenile diabetes]. Pol Arch Med Wewn (1974) 0.75
[Prostaglandins, islands of Langerhans and glucose homeostasis]. Pol Tyg Lek (1984) 0.75
[Comparison of the anorectic effect of mazindol and placebo in obesity]. Pol Tyg Lek (1979) 0.75
[Classification and epidemiology of arterial hypertension in patients with diabetes mellitus]. Pol Tyg Lek (1984) 0.75
[Clinical aspects of the genetics of diabetes mellitus]. Ginekol Pol (1971) 0.75
[The use of methods applied in the study of cellular hormone receptors in clinical physiopathology]. Pol Arch Med Wewn (1975) 0.75
[Problems of the philosophy of medicine: who is responsible for health?]. Pol Tyg Lek (1985) 0.75
Role of disturbed metabolism of fat tissue cells in the pathogenesis of the diabetogenic effect of obesity in humans. Pol Med Sci Hist Bull (1977) 0.75
[Education of patients with diabetes mellitus as a method of treatment]. Pol Tyg Lek (1982) 0.75
[Case for discussion. Problems of diagnosis and clinical management of multi-etiological infection in a patient with collagenosis and long-term corticoid therapy]. Pol Tyg Lek (1983) 0.75
Quality of life after simultaneous pancreas-kidney transplantation. Transplant Proc (2005) 0.75
[Autoimmune polyendocrinopathy in insulin-dependent diabetes mellitus]. Pol Tyg Lek (1987) 0.75
[Basal and reactive renin and aldosterone secretion in arterial hypertension of insulin dependent diabetics]. Pol Tyg Lek (1993) 0.75
[Comparison of the effects of chromatographically purified insulin TZF-Polfa and highly purified insulin Nordisk on insulin-induced lipoatrophy]. Pol Tyg Lek (1987) 0.75
[Aspects of medical philosophy: medical intervention and the system of human values]. Pol Tyg Lek (1985) 0.75
Retrospective analysis of cardiovascular outcomes in patients with type 2 diabetes mellitus after the first acute myocardial infarction. Acta Diabetol (2003) 0.75
[Problems of medical philosophy: remarks on the ethics of institutions and medical health care teams]. Pol Tyg Lek (1985) 0.75
[Glycosylated hemoglobin as an indicator of treatment effectiveness in various types of diabetes]. Pol Arch Med Wewn (1983) 0.75
[Specificity of drug therapy of hypertension in patients with diabetes mellitus]. Pol Tyg Lek (1989) 0.75
[Social environment and health]. Pol Tyg Lek (1983) 0.75
[Human--medical and philosophical expression]. Pol Tyg Lek (1994) 0.75
[Computation of the number of diabetics, the determination of recessive genotypes and the incidence of diabetic alleles in the Polish population over the age of 14]. Pol Arch Med Wewn (1970) 0.75
[Evaluation of the reactivity of the adrenergic system using the isoproterenol test in diabetes mellitus type 1]. Pol Tyg Lek (1987) 0.75
[Diagnosis of visceral neuropathy in diabetics by means of simple function tests]. Pol Tyg Lek (1982) 0.75
[Philosophical concept of man and medicine]. Pol Tyg Lek (1983) 0.75
[Clinical forms of the diabetic ketoacidosis course (author's transl)]. Przegl Lek (1979) 0.75
[Our modification of the method of determining plasma glibornuride and the evaluation of its usefulness in clinical and pharmacological studies]. Pol Tyg Lek (1982) 0.75
[Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus]. Pol Tyg Lek (1984) 0.75
[Fructosamine levels as an indicator of the glycosylation of serum proteins in diabetes mellitus type 1: clinical significance]. Pol Tyg Lek (1987) 0.75
[Mechanisms of the pathogenesis of diabetic macroangiopathy]. Pol Tyg Lek (1982) 0.75
[Radiological changes suggesting small infiltration in the stomach. Differential diagnosis and management]. Pol Tyg Lek (1969) 0.75
[Pathogenetic and clinical observations on 23 cases of non-ketonemic hypermolal (hypermosmolal) coma in patients with diabetes mellitus (author's transl)]. Przegl Lek (1979) 0.75
[Diabetes--reflections on the problem]. Pol Tyg Lek (1982) 0.75
Glycosylated hemoglobin (Hb AI) as an indicator of therapy effects in different clinical types of diabetes. J Chronic Dis (1983) 0.75
[Monotherapy with acebutolol in hypertensive diabetic patients]. Pol Tyg Lek (1990) 0.75
[Metabolic basis of pathogenesis of lactic acid acidosis (author's transl)]. Przegl Lek (1979) 0.75
[Diagnosis at the patient's bedside - can it be improved?]. Pol Tyg Lek (1983) 0.75